Table 4.
The effects of BDNF-CpGs by Inflammatory markers.
| GzLM models - Inflamatory markers | |||||||
|---|---|---|---|---|---|---|---|
| β | SE | 95% CI |
Wald ꭓ2 | P-value | P-value adja | ||
| Min | Max | ||||||
| IL-6 (pg/mL)versus %DNA methylation (BDNF - CpGs) | |||||||
| CpG5 | 0.235 | 0.119 | 0.001 | 0.468 | 3.887 | 0.049 | 0.243 |
| CpG6 | −0.031 | 0.026 | −0.082 | 0.019 | 1.498 | 0.221 | 0.473 |
| CpG7 | −0.028 | 0.024 | −0.075 | 0.018 | 1.406 | 0.236 | 0.393 |
| CpG8 | −0.009 | 0.014 | −0.036 | 0.018 | 0.450 | 0.502 | 0.685 |
| CpG9 | −0.005 | 0.019 | −0.042 | 0.032 | 0.071 | 0.790 | 0.911 |
| CpG10 | 0.006 | 0.036 | −0.064 | 0.077 | 0.032 | 0.858 | 0.919 |
| CpG11 | −0.004 | 0.024 | −0.051 | 0.044 | 0.023 | 0.879 | 0.879 |
| CpG12 | −0.027 | 0.030 | −0.085 | 0.031 | 0.828 | 0.363 | 0.544 |
| CpG13 | 0.051 | 0.027 | −0.001 | 0.103 | 3.640 | 0.056 | 0.211 |
| IL-8 (pg/mL)versus%DNA methylation (BDNF - CpGs) | |||||||
| CpG5 | −0.022 | 0.018 | −0.058 | 0.014 | 1.424 | 0.233 | 0.436 |
| CpG6 | −0.034 | 0.022 | −0.077 | 0.009 | 2.348 | 0.125 | 0.471 |
| CpG7 | −0.020 | 0.020 | −0.059 | 0.019 | 0.982 | 0.322 | 0.439 |
| CpG8 | 0.006 | 0.011 | −0.015 | 0.027 | 0.330 | 0.566 | 0.707 |
| CpG9 | 0.019 | 0.015 | −0.009 | 0.048 | 1.741 | 0.187 | 0.467 |
| CpG10 | 0.031 | 0.029 | −0.026 | 0.089 | 1.142 | 0.285 | 0.428 |
| CpG11 | −0.030 | 0.019 | −0.068 | 0.008 | 2.341 | 0.126 | 0.378 |
| CpG12 | −0.028 | 0.023 | −0.074 | 0.018 | 1.436 | 0.231 | 0.495 |
| CpG13 | 0.047 | 0.021 | 0.005 | 0.089 | 4.869 | 0.027 | 0.205 |
| IL-10 (pg/mL)versus%DNA methylation (BDNF - CpGs) | |||||||
| CpG5 | −0.009 | 0.005 | −0.019 | 0.002 | 2.732 | 0.098 | 0.239 |
| CpG6 | 0.004 | 0.006 | −0.007 | 0.016 | 0.585 | 0.444 | 0.581 |
| CpG7 | 0.008 | 0.006 | −0.003 | 0.018 | 1.822 | 0.177 | 0.301 |
| CpG8 | −0.002 | 0.003 | −0.007 | 0.004 | 0.413 | 0.520 | 0.590 |
| CpG9 | 0.003 | 0.004 | −0.005 | 0.010 | 0.433 | 0.510 | 0.620 |
| CpG10 | −0.001 | 0.026 | −0.052 | 0.050 | 0.002 | 0.962 | 1.000 |
| CpG11 | −0.093 | 0.030 | −0.152 | −0.033 | 9.341 | 0.002 | 0.010 |
| CpG12 | 0.000 | 0.006 | −0.012 | 0.012 | 0.000 | 0.995 | 0.995 |
| CpG13 | −0.007 | 0.006 | −0.018 | 0.005 | 1.224 | 0.269 | 0.380 |
| IL-12p70 (pg/mL)versus%DNA methylation (BDNF - CpGs) | |||||||
| CpG5 | 0.287 | 0.113 | 0.066 | 0.508 | 6.492 | 0.011 | 0.022 |
| CpG6 | 0.027 | 0.071 | −0.113 | 0.167 | 0.142 | 0.707 | 0.707 |
| CpG7 | −0.263 | 0.077 | −0.415 | −0.112 | 11.576 | 0.001 | 0.005 |
| CpG8 | 0.089 | 0.048 | −0.004 | 0.183 | 3.512 | 0.061 | 0.077 |
| CpG9 | −0.274 | 0.122 | −0.513 | −0.035 | 5.031 | 0.025 | 0.040 |
| CpG10 | 0.057 | 0.036 | −0.014 | 0.128 | 2.494 | 0.114 | 0.137 |
| CpG11 | −0.455 | 0.145 | −0.739 | −0.171 | 9.867 | 0.002 | 0.006 |
| CpG12 | 0.051 | 0.058 | −0.063 | 0.165 | 0.766 | 0.382 | 0.398 |
| CpG13 | 0.514 | 0.138 | 0.244 | 0.784 | 13.918 | 0.000 | 0.005 |
Note: Generalized linear models obtained with Gamma distribution. P-values were presented based on Wald's chi-square test (Wald ꭓ2) and were adjusted by FDR (False Discovery Rate). P < 0.05 (IC = 95%); CpG: DNA methylation sites of BDNF.
FDR: False Dicovery Rate.